ライフサイエンスコーパス: body image

1 after radiotherapy, but with no detriment to body image.

2 ved in all psychosocial subscales except for body image.

3 nificant change scores were observed only in body image.

4 with relationships, sexual functioning, and body image.

5 tion but received mastectomy had the poorest body image.

6 argeting autoimmunity to correcting abnormal body image.

7 ctivity, healthy eating, and self-esteem and body image.

8 treatments that intervene to manipulate the body image.

9 h included quality of life, self-esteem, and body image.

10 a task that yields quantitative measures of body image.

11 nistered to enhance athletic performance and body image.

12 ar vertebrae in anterior and posterior whole-body images.

13 es were obtained; this was followed by whole-body images.

14 -410 MBq anti-(18)F-FACBC followed by static body images.

15 ms for quantitative, three-dimensional whole-body images.

16 pened animal confirmed the identity of whole-body images.

17 es, with a strong selectivity for individual body images.

18 e neurons responded to a small proportion of body images.

19 bined with organ-based analysis of the whole-body images.

20 ate tissue well, IFPs are suitable for whole-body imaging.

21 or typical scan lengths at clinical head and body imaging.

22 regression of xenografts visualized by whole-body imaging.

23 alized directly by gamma-scintigraphic whole-body imaging.

24 ve of clinical studies, in particular, whole-body imaging.

25 kanamycin treatment were visualized by whole-body imaging.

26 er gavage was followed in real-time by whole-body imaging.

27 over a 10-day period as determined by whole-body imaging.

28 unknown areas of disease when used for full-body imaging.

29 p radiolabelling allowed complementary whole-body imaging.

30 the question of how the brain constructs a 'body image.'

31 ical health (0.94), emotional health (0.94), body image (0.89), pain (0.92), planning (0.93), fatigue

32 who received breast conservation had better body image 2 years after treatment than women who had ma

33 of these technologic advances include whole-body imaging, 3-dimensional imaging, new scintillator ma

34 essive symptoms were associated with altered body image (35% of the variance, P < .001).

35 reflux (63%), eating restrictions (45%), and body image (44%), which persisted after PTG.

36 were a validated cosmesis (3-24 points) and body image (5-20 points) score after 3 and 12 months.

37 nctional scales, APR patients reported worse body image (70.3 vs 77.0, P = 0.0005) at 1 year than did

38 ences in tissue types in, for example, whole-body imaging, a set of tissue homogenates of different t

39 The common distortions in body image across patient groups, despite differing SCI

40 nsgenic (luciferase) reporter mice and whole-body imaging, allowing noninvasive quantification of tra

41 ldren with pectus carinatum have a disturbed body image and a reduced quality of life.

42 more emphasis in society is placed on one's body image and appearance there has been an increase in

43 nal procedures and hospital admissions), and body image and cosmesis.

44 most domains of quality of life, as well as body image and depressive symptoms, within the first yea

45 sses characterized by marked disturbances in body image and eating patterns.

46 wn about the impact of surgical treatment on body image and health outcomes in older breast cancer pa

47 ntary explores the potential implications of body image and its distortions for the insurance hypothe

48 tion has the potential to improve a person's body image and quality of life but has important risks.

49 pectus carinatum are at risk for a disturbed body image and reduced quality of life.

50 image in female breast cancer survivors, the Body Image and Relationships Scale (BIRS), was developed

51 treatment preferences predicts posttreatment body image and whether body image, in turn, affects ment

52 Whole-body images and spot views of the neck and chest were ob

53 ion of human tumor-host interaction by whole-body imaging and at the cellular level in fresh and froz

54 sualizes the tumor-host interaction by whole-body imaging and at the cellular level in fresh tissues,

55 Serial whole-body imaging and blood sampling were performed up to 24

56 Planar whole-body imaging and SPECT/CT were performed from thorax to

57 e to a neurologically determined disorder of body-image and bodyego induced by peripheral injury.

58 rted for the areas of family dysfunction and body image, and few studies have been published in the a

59 Sexual function, self-esteem, body image, and general health of female patients underg

60 ould be explained by changes in self-esteem, body image, and intrusive thoughts about the illness.

61 has salutary effects on sexual functioning, body image, and menopausal symptoms in BCSs with a sexua

62 (PCS), symptom resolution and satisfaction, body image, and sexual functioning, as well as other asp

63 on of the body external appearance, i.e. the body image, and suggest the existence of two functionall

64 two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial coloniz

65 Tumors are tracked in living mice by whole-body imaging, and macrometastases or micrometastases are

66 Fully quantitative whole-body images are obtained for an axial extent of 100 cm i

67 r Physical, Role and Social Functioning, and Body Image, as well as for Mobility, Self-care, and Pain

68 ble covalently bound product C3d by external body imaging, as a marker of complement activation in he

69 For whole-body imaging, as a measure of radiation exposure to the

70 Whole-body images at this time showed only bladder, kidneys an

71 -MFBG intravenously followed by serial whole-body imaging at 0.5-1, 1-2, and 3-4 after injection.

72 but their limited diffusion precludes whole-body imaging at visceral sites.

73 Body image, avoidance coping, referral to the study by a

74 urse of treatment, noninvasive optical whole-body imaging based on brilliant red fluorescent protein

75 tter physical functioning (P = .006), better body image (BI; P < .001), less pain (P < .001) and its

76 om involved organs is an obstacle that whole-body imaging can help overcome.

77 Whole-body imaging can provide information across lesions with

78 SPLC-group showed superior mean cosmesis and body image compared with the 4PLC-group at 12-weeks (21

79 ients with ARVD/C had substantially elevated body image concerns (Florida Patient Acceptance Survey s

80 Breast symptoms and body image concerns reduced over time.

81 ure of support required from partners and in body image concerns.

82 al treatment of eating disorders and related body-image concerns in middle-aged and elderly women.

83 Conduct disorder and body-image concerns represent important risk factors for

84 ation with AAS use, but conduct disorder and body-image concerns showed strong associations.

85 We hypothesized that conduct disorder and body-image concerns would be major risk factors for subs

86 l and psychological aspects of sexuality and body image, CSA was not a significant predictor of physi

87 thyroid carcinoma, and on radioiodine total-body imaging demonstrated focal, lower-right chest uptak

88 Quality of life, body image, depressive symptoms, and marital adjustment

89 A body image discrepancy score was calculated from the dif

90 at clinicians should be alert for eating and body-image disorder even in women well beyond the younge

91 ntral body fat deposition is associated with body image dissatisfaction and suggest that it may repre

92 ages has been linked to eating disorders and body image dissatisfaction in men, women, and children.

93 Body-image dissatisfaction in AN patients was not relate

94 be anhedonic, hunger and pain are muted, and body-image distortion obscures wasting, which together f

95 Body image distortions are a core feature of anorexia ne

96 Body image distortions are a core feature of anorexia ne

97 Body image distortions are common in healthy individuals

98 Research on body image distress suggests the importance of changes i

99 anxiety, fatigue and sleep, pain, pruritus, body image distress, sexual function, work disability, h

100 Although body image disturbance is considered one of the core cha

101 ry perceptual information that might sustain body image disturbance.

102 ), as increased levels of depersonalization, body image disturbances, and reduced sensitivity to phys

103 gly common in older women, as are associated body-image disturbances.

104 of self-esteem, attitudes toward male roles, body image, eating-related attitudes and behaviors, and

105 ention group reported greater improvement in body image (EST2 = .45; P = .009) and fewer menopausal s

106 use of avoidant coping strategies, negative body image, feelings of fear and uncertainty in relation

107 Four observers (experienced sonologist, body imaging fellow, 1st-year radiology resident, and pr

108 ed by radiology residents or board-certified body imaging fellows over a 12-month period.

109 We used RIA, whole body imaging, flow cytometry, and fluorescence immunohis

110 Systematic alterations in body image follow SCI although our results suggest these

111 times in the Patlak images than in the whole-body images for (68)Ga-DOTATOC and (68)Ga-DOTATATE, resp

112 art for 10 min, followed by sequential whole-body images for approximately 5 h.

113 the parametric Ki images compared with whole-body images for both (68)Ga-DOTATOC and (68)Ga DOTATATE.

114 ased with increasing scan rate, useful whole-body images for propranolol were obtained from the tissu

115 art for 10 min, followed by sequential whole-body imaging for 5 h.

116 hese results show the potential use of whole-body imaging for receptor status assessment, particularl

117 General psychosocial benefits and body image gains continued to manifest at 2 years postma

118 Body image improved, with slight changes at 6 months and

119 A self-report measure of body image in female breast cancer survivors, the Body I

120 ining eating disorders, eating behavior, and body image in middle-aged and elderly women.

121 Introduced bacteria can be whole-body imaged in most mouse organs, including the peritone

122 PET whole body imaging in cancer provides the means to (i) identif

123 A method based on repeated whole-body imaging in combination with blood and urinary activ

124 Early whole-body imaging in conjunction with delayed whole-body scan

125 tic sensitivities of (123)I and (131)I whole-body imaging in differentiated thyroid cancer.

126 redicts posttreatment body image and whether body image, in turn, affects mental health in older wome

127 eralized estimating equations, we found that body image, in turn, predicted 2-year mental health.

128 recurrence support performing regular whole-body imaging initially every 6 to 12 months and continui

129 t, including sexual identity), their bodies (body image), initiating intimate and emotional relations

130 h cancer, aiming to improve sexual response, body image, intimacy and relationship issues, and overal

131 How this body image is affected by changes in sensory inputs from

132 s of sexual satisfaction, orgasm and patient body image is essential, however, to allow a comparison

133 Body image is important for many older women, and receiv

134 se findings provide new insight into how the body image is maintained, and may prove useful in treatm

135 of their body, suggesting that the conscious body image is not fully determined by immediate sensory

136 sting revealed that the encoding capacity of body images is higher than that of characters, faces, an

137 valently used molecular imaging technique in body imaging is currently fluorine 18 fluorodeoxyglucose

138 with sex life, feeling sexually attractive, body image, marital satisfaction, quality of life, medic

139 In particular, we speculate that body image may be an intervening variable mediating the

140 , despite differing SCI levels, imply that a body image may be maintained despite chronic sensory and

141 relationship intimacy (primary outcomes) and body image, menopausal symptoms, marital functioning, ps

142 d therefore EUS is usually performed after a body imaging modality such as computed tomography or pos

143 (18)F-FDG PET is a molecular whole-body imaging modality that is increasingly being used fo

144 righter, red-shifted proteins can make whole-body imaging more sensitive owing to reduced absorption

145 For whole-body imaging, nude mice are very appropriate.

146 Whole body images of anesthetized mice taken at various time p

147 pendently analyzed all 7 reconstructed whole-body images of each patient.

148 omputed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumor site

149 Whole-body imaging of 12 patients, who received 111-185 MBq (3

150 ith the exception of liver metastases, whole-body imaging of ER expression with (18)F-FES PET can be

151 sed imaging technology can be used for whole-body imaging of fluorescent cells on essentially all org

152 taneous recurrence (TxN2bM0) underwent whole-body imaging of glucose metabolism with fluorodeoxygluco

153 to engineer mouse melanoma models for whole-body imaging of metastasis generated by human cells, cli

154 n offers the potential for noninvasive whole-body imaging of numerous cellular and molecular processe

155 nts; demonstrated here is MALDI-IMS-MS whole body imaging of rats dosed at 6 mg/kg i.v. with an antic

156 It allows noninvasive, whole-body imaging of the FR.

157 Real-time whole-body imaging of the live animals confirmed improved tumo

158 objectives"), is used for three-color whole-body imaging of the two-color cancer cells interacting w

159 (PET) reporter genes allow noninvasive whole-body imaging of transplanted cells by detection with rad

160 dvantage of to develop a technology of whole-body imaging of tumors and gene expression in mouse inte

161 On many indices of disordered eating and body image, older women with eating disorder resemble yo

162 l and Social Function, Role Functioning, and Body Image on EORTC QLQ-C30/QLQ-CR38 analysis and Mobili

163 All patients underwent whole-body imaging on a PET/CT device 1 h after (18)F-FDG inje

164 uent to breast reconstruction (ie, effect on body image or psychosocial well-being).

165 increased by a factor of about 40 for total-body imaging or a factor of about 4-5 for imaging a sing

166 Healthy volunteers underwent serial whole-body imaging over an approximately 3-h interval, and org

167 On whole-body imaging, P-gp blockade significantly affected distr

168 The impact of SPLC on improving cosmesis, body image, pain, and QoL has not been evaluated in doub

169 Both body-image pathology and narrow stereotypic views of mas

170 and on previous observations suggesting that body-image pathology is associated with illicit use of a

171 re not found to be significant predictors of body image perception (p > 0.05).

172 In this study, the authors examined body image perception and body mass index (weight (kg)/h

173 difference between z-standardized values of body image perception and body mass index.

174 rences exist within racial groups concerning body image perception in relation to overweight status a

175 As part of the survey, body image perception was determined in terms of body sh

176 individual patients to directly assess their body image perception.

177 ment, time since treatment, poor self esteem/body image, physical symptoms, poor performance status,

178 g superior short- and long-term cosmetic and body image, postoperative pain, and QoL in SPLC compared

179 ly after diagnosis; relationship, sexual, or body image problems after diagnosis; and coping strategi

180 d after diagnosis; relationship, sexual, and body image problems; coping strategies; and feelings of

181 ope distribution using (18)F-FDG and a whole-body imaging protocol to demonstrate proof-of-principle.

182 sttransplant, patient and team expectations, body image, psychiatric complications, functional goals

183 atients, including issues such as changes in body image, quality of life, anxiety, and guilt.

184 Whole-body imaging revealed that the cells retained their abil

185 nation and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporally and

186 luation Subscale (AES) score (range, 1-5), a Body Image Satisfaction (BIS) score (range, 2-11), and r

187 Function Index, Rosenberg Self-Esteem scale, Body Image scale and SF-36, respectively.

188 Depression Scale, and a summary scale of the Body Image Scale.

189 Body-image scale mean scores in the patients who had res

190 s of breast cancer, mental health score, and body image score.

191 ous flaps had significantly greater gains in body image scores (P = 0.003 and P = 0.034, respectively

192 sis identified 9 themes: Bonding/Attachment; Body Image; Self Esteem/Confidence; Female Role Models;

193 d data regarding the usefulness of brain and body imaging, serum and cerebrospinal fluid (CSF) studie

194 E) on menopausal symptoms (primary outcome), body image, sexual functioning, psychological well-being

195 to assess contentment with quality of life, body image, sexual satisfaction, breast cancer concern,

196 In March 2003, self-referred body imaging (SRBI) centers were identified by using the

197 rk Skin versus the Short-Form-12, PVC Metra, Body Image States Scale, and Daily Life Quality Index as

198 an optimal combination for dual color, whole body imaging studies in model animals.

199 t protein-transfected cancer cells and whole-body imaging system.

200 ositron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeoxygluc

201 st devised by the authors, the men chose the body image that they felt represented 1) their own body,

202 able (vaginal dryness, emotional well-being, body image, the quality of the partnered relationship, a

203 Here, we use whole-body imaging to determine the efficacy and kinetics of f

204 applications, enabling the noninvasive whole-body imaging to localize disease and identification of t

205 hy but was obvious on post-therapeutic whole-body imaging, underscoring the value of post-therapy ima

206 Body image was an important factor in treatment decision

207 Body image was measured using questions adapted from the

208 Whole-body imaging was carried out with either a trans-illumin

209 period of thyroid hormone withdrawal, whole-body imaging was performed approximately 24 and 72-96 h

210 8)F-FDG were administered and repeated whole-body imaging was performed.

211 and confocal microscopy, together with whole-body imaging, we measured tumor growth delay, survival r

212 Whole-body images were acquired 30 min after injection of 5-15

213 For the first 22 patients, whole-body images were acquired at 15 min and at 1, 2, 3, and

214 biodistribution and dosimetry, serial whole-body images were acquired immediately after injection an

215 Transmission scans and whole-body images were acquired sequentially on a dual-head ca

216 Whole-body images were obtained approximately 1 h after inject

217 Whole-body images were obtained at 10 min and 1, 2, 4, and 24

218 inistered as an intravenous bolus, and whole-body images were obtained at 30 min, 4 h, and (for the f

219 Whole-body images were obtained for each subject (mean +/- SD,

220 Whole-body images were obtained on these patients 7 d after 13

221 multaneous anterior and posterior view whole-body images were obtained under identical scan settings

222 Anterior and posterior spot views and whole-body images were obtained.

223 Using an iterative algorithm, whole-body images were reconstructed as transaxial, sagittal,

224 in brain and liver became visible, and whole-body images were recorded at video rates.

225 The whole-body images were used for real-time, quantitative measur

226 In, for example, whole-body imaging where a diversity of tissue types are prese

227 esonance (MR) imaging and fluorescence whole body imaging, which respectively tracked iron oxide part

228 uclide bone scan, chest radiograph, or other body imaging, which was performed at the time of biochem

229 Forty patients underwent baseline whole-body imaging with 99mTc-sulfur colloid and evaluation of

230 f non-small cell lung cancer underwent whole-body imaging with a sequential trimodality PET/CT/MR sys

231 ng of oncologic malignancies underwent whole-body imaging with a sequential trimodality PET/CT/MR sys

232 Whole-body imaging with fluorescent proteins is a powerful tec

233 (18)F-FDG PET/CT scans (whole-body imaging with low-dose CT) of 24 consecutive patient

234 study of 62Cu-PTSM was performed using whole-body imaging with PET in 10 healthy volunteers and with

235 Whole-body imaging, with scintimammography and PET, and newer